Curcumin & Astaxanthin for Lowering Triglyceride Readings and Inflammation
Launched by MEDINUTRA LLC · Jul 3, 2025
Trial Information
Current as of August 29, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at whether two natural supplements, curcumin and astaxanthin, can help keep triglyceride levels— a type of fat found in the blood—within a healthy range. High triglycerides can increase the risk of heart problems, so researchers want to see if taking one capsule a day of either supplement for six weeks can lower these levels compared to a placebo (a pill with no active ingredients). They will also check some blood markers related to low-level inflammation, which is connected to heart health.
Adults with moderately high triglyceride levels (between 140 and 250 mg/dL) may be eligible to join, as long as they don’t have certain conditions like uncontrolled diabetes, active liver disease, cancer, or inflammatory illnesses, and aren’t pregnant or breastfeeding. Participants will have their blood tested before starting and after six weeks of taking the supplement or placebo. This study hasn’t started recruiting yet, but if you qualify, it offers a way to see if these supplements might help manage triglycerides and inflammation safely.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Triglyceride reading of 140-250 mg/dL
- • Age 21-59
- Exclusion Criteria:
- • Uncontrolled diabetes
- • Hypothyroidism or other hormonal problems that have not stabilized
- • Any liver diseases being actively treated
- • Cancer
- • Renal dialysis use
- • Rheumatoid arthritis and related issues like lupus
- • Inflammatory bowel disease
- • Smoking
- • Low blood pressure
- • Having more than 5 alcoholic drinks per week
- • Extreme obesity (BMI over 37)
- • Pregnancy or lactation
About Medinutra Llc
Medinutra LLC is a clinical research organization specializing in the development and evaluation of nutritional and dietary supplements aimed at improving health and wellness. Committed to scientific rigor and innovation, Medinutra LLC conducts clinical trials to advance evidence-based solutions that support optimal nutrition and enhance quality of life. Their focus encompasses a broad range of therapeutic areas, leveraging multidisciplinary expertise to deliver safe and effective nutraceutical products to the market.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Dublin, Ohio, United States
Patients applied
Trial Officials
Robert DiSilvestro, Ph.D.
Principal Investigator
Medinutra LLC
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported